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Neurogenesis is an important process in the regulation
of brain function and behaviour, highly active in early
development and continuing throughout life. Recent
studies have shown that neurogenesis is modulated
by inflammatory cytokines in response to an activated
immune system. To disentangle the effects of the differ-
ent cytokines on neurogenesis, here we summarise and
discuss in vitro studies on individual cytokines. We show
that inflammatory cytokines have both a positive and
negative role on proliferation and neuronal differentia-
tion. Hence, this strengthens the notion that inflamma-
tion is involved in molecular and cellular mechanisms
associated with complex cognitive processes and, there-
fore, that alterations in brain–immune communication
are relevant to the development of neuropsychiatric
disorders.
Building, refining, and modulating neural circuits
Neurogenesis is as a complex neurobiological process by
which new neurons are generated from neural stem cells
(NSCs) [1]. The ability of stem cells to self-renew and then
differentiate into specific cell subtypes has been demon-
strated both in vitro [2] and, more recently, in vivo [3]. For
this reason, the term ‘neural progenitor cells’ (NPCs) is
now used to loosely define all dividing cells with some
ability to generate different neural units [3]. Current data
have estimated that approximately 700 new neurons are
added to the adult human hippocampus daily, suggesting
that adult hippocampal neurogenesis has a critical role in
mediating human brain functions, such as memory forma-
tion and cognition [4,5]. In rodents, two neurogenic niches
are located in specific regions of the brain: the subventri-
cular zone (SVZ) of the lateral ventricles and the subgra-
nular zone (SGZ) of the dentate gyrus (DG) in the
hippocampus. Neurons generated in the adult SVZ migrate
through the rostral migratory stream and develop into
granule neurons and periglomerular neurons in the olfac-
tory bulb (OB). Neurons generated in hippocampal adult
SGZ migrate into the DG and become dentate granule cells
(Figure 1) [3]. Likewise, adult neurogenesis in humans also
occurs in both the SVZ and the SGZ; however, newborn
neurons in the SVZ follow a putative migration towards the
striatum (STR), where they finally develop into mature
neurons (Figure 2) [6]. Unfortunately, neurogenesis in the
adult brain is too limited to repair central nervous system
(CNS) damage [7]. However, understanding how it is reg-
ulated might suggest ways in which it can be harnessed to
promote regeneration after brain insult [7]. Moreover, reg-
ulation of adult hippocampal neurogenesis is crucial to the
development of depressive behaviour and the ability to
cope with stress [8].
NSCs and NPCs are continuously stimulated to prolif-
erate, migrate, differentiate, and survive. However, any
pathological perturbation to the brain, including injury,
insult, or infection, can threaten normal CNS stability,
provoking a cascade of molecular and cellular events that
occurs mostly through microglial activation and a concom-
itant release of various inflammatory mediators, particu-
larly cytokines [9]. Cytokines can have a substantial role in
the brain [10]: on the one hand, they can confer immune
protection, clearing the system from dead and damaged
neurons and, on the other hand, they can exert certain
detrimental effects on NSC niches, leading to neuronal
death [11].
Although several studies have focused on both pro-and
anti-inflammatory cytokines, with respect to their either
positive or negative effects on neurogenesis [10], there is
still the need for further understanding of their contribu-
tion in modulating cell differentiation and survival. To
clarify this issue, here we review in vitro (cellular) studies
that investigate the effect of individual cytokines on cell
proliferation and differentiation of NPC types from differ-
ent donor tissue and species. In addition, we give an
overview of the molecular mechanisms underlying the
described effects.
The role of inflammatory cytokines on brain function
and neurogenesis
Cytokines are low-molecular-weight regulatory proteins or
glycoproteins secreted by various cells in the body, includ-
ing white blood cells, in response to an inflammatory
stimulus [12]. Many cytokines are referred to as interleu-
kins (ILs), a name indicating that they are secreted by
some leukocytes and act on other similar cell types
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[13]. Two other important types of cytokine include inter-
ferons (IFNs), which have the ability to activate immune
cells such as natural killer cells and macrophages [14], and
tumour necrosis factors (TNFs), which have been implicat-
ed in causing cell death [15]. In the brain, these inflamma-
tory mediators have the important role of conferring
immune protection and clearing the system from dead
and damaged neurons, as well as exerting physiological
and even neuroprotective functions [16]. By contrast, acti-
vation of peripheral inflammation is associated with in-
creased expression of cytokines in the neurogenic niches
[17], which directly impairs hippocampal-dependent forms
of synaptic plasticity [18], potentially leading to cognitive
impairment [19].
Cytokines have a central role in CNS functions
[9,20]. Emerging evidence suggests that, during an inflam-
matory response, cytokines influence the neurogenic niche
and regulate NPC proliferation and neurogenesis, partic-
ularly in the context of psychiatric and neurodegenerative
conditions [21,22]. Indeed, overexpression of proinflamma-
tory cytokines has been associated with several neuropsy-
chiatric disorders, such as depression [23], and
neurodegenerative diseases, including Alzheimer’s disease
(AD) and Parkinson’s disease (PD) [24,25]. Patients with
major depressive disorder (MDD) exhibit both increased
immune activation and aberrant regulation of neuronal
plasticity, including neurogenesis [26], which have been
linked with abnormal cellular immunity [10]. Particularly,
recent meta-analyses have reported significant upregula-
tion of immune molecules, particularly IL-1b, IL-6, and
TNF-a, in both serum and plasma of patients with depres-
sion [27]. These distinct cytokines, together with the trans-
forming growth factor beta (TGF-b), are involved in the
molecular and cellular mechanisms associated with com-
plex cognitive processes, such as mood and learning func-
tions [28]. Moreover, IL-1, together with IL-18 and TNF-a,
contributes to inhibition of synaptic plasticity and memory
consolidation [20,29], as reported in patients with MDD or
in experimental models of depression [23]. Similar abnor-
malities have also been reported in PD and AD, which are
conditions characterised by progressive neurodegenera-
tion as well as by an abnormal immune response, due to
hyperstimulation of microglia to produce inflammatory
cytokines [10]. For example, in a mouse model of progres-
sive PD, neurodegeneration was associated with an upre-
gulation of IL-1b and TNF-a [30]. Similarly, brains of
patients with AD showed increased production of IL-1
[31], together with an increased depletion of the neural
progenitor pool in distinct neurogenic areas, including the
SVZ [32]. Several pathways by which cytokines may cause
damage to PD and AD brains have been proposed [33–
35]. Overall evidence suggests that cytokines induce an
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Figure 1. Illustration of the sagittal view of a rodent brain showing the two neurogenic niches: the subventricular zone (SVZ) of the lateral ventricles and the subgranular
zone (SGZ) of the dentate gyrus (DG) in the hippocampus. (A) Neural progenitor cells (NPCs) generated in the adult SVZ proliferate (1), migrate through the rostral
migratory stream (RMS) (2) and develop into granule neurons and periglomerular neurons in the olfactory bulb (OB) (3). (B) NPCs generated in the adult SGZ of the DG
proliferate (1), migrate into the granule cell layer (2) and mature into new granule neurons (3), extending projections into the CA3 region of the hippocampus.
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inflammatory response mainly via glial activation, which
subsequently leads to cell neurodegeneration [29]. These
results support the hypothesis that neuroinflammatory
changes are key pathological components of MDD as well
as PD and AD, and highlight the potential clinical impor-
tance of the effects of cytokines on neurogenesis.
The effects of cytokines on neurogenesis
This section of the review is organised into six subsections,
each one describing the effect of specific cytokines on cell
generation: ILs (Table 1A–C), IFNs (Table 1D), and TNFs
(Table 1E). In each subsection, we first describe the studies
that assessed adult neurogenesis, using either human cells
(from the DG) or rodent cells (from the DG or SVZ). Second,
we report those studies that investigated fetal develop-
mental neurogenesis, using either human or rodent cells
taken from other brain regions. In addition, if available, we
discuss the molecular mechanisms underlying the de-
scribed effects. Given that we reviewed articles using
different NPC types from different donor tissue and spe-
cies, in Table 1 we have also highlighted the different
neurogenesis markers used within each study, and Box
1 provides further insight into the role of markers for the
detection of NPCs during the phase of proliferation and
differentiation. Table 2 gives an overview of the findings,
and Box 2 discusses their relevance for in vivo brain
function.
IL-1a and IL-1b
IL-1a increases neurogenesis in vitro whereas, in most
studies, IL-1b reduces NPC proliferation and neuronal
differentiation, and enhances gliogenesis (Table 1A). This
is different from in vivo studies, where evidence suggests
that both IL-1a and IL-1b have inhibitory influence on
hippocampal neurogenesis upon treatment [36]. However,
this discrepancy between in vitro and in vivo studies may
be partly explained by the different brain cells used in
vitro, because IL-1a has a stimulatory effect in mesence-
phalic cells (in the only in vitro study) [37], while IL-1b has
stimulatory effects in mesencephalic cells [37] but inhibi-
tory effects in hippocampal cells [38,39].
IL-1b decreased proliferation and neurogenesis in rat adult
DG NPCs, whereas co-treatment with IL-1 receptor antago-
nist (ra) prevented the negative effect of IL-1b on cell prolifer-
ation [40]. Likewise, IL-1b reduced proliferation and
differentiation of rat neonatal DG NPCs into serotonergic
(5-hydroxytryptamine; 5-HT) neurons. Accordingly, treat-
ment with IL-1ra blocked the inhibiting effect of IL-1b on
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Figure 2. Illustration of the sagittal view of a human brain showing the two neurogenic niches: the subventricular zone (SVZ) of the lateral ventricles and the subgranular
zone (SGZ) of the dentate gyrus (DG) in the hippocampus. (A) Neural progenitor cells (NPCs) generated in the adult SVZ proliferate and follow a putative migration towards
the striatum where they develop into mature neurons. (B) NPCs generated in the adult SGZ of the DG proliferate and reside into the granule cell layer where they mature
into new granule neurons, extending projections into the CA3 region of the hippocampus.
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Table 1. Studies examining the effect of inflammatory cytokines on cell proliferation, gliogenesis, neurogenesis, cell migration, and apoptosisa,b
Inflammatory challenge Cell type Markers for: Findings Refs
Proliferation Gliogenesis Neurogenesis Cell
migration
Apoptosis Proliferation Gliogenesis Neurogenesis Cell
migration
Apoptosis
A. IL-1a and IL-1b
IL-1b Human fetal HNPCs GFAP b-III-tubulin " # [43]
Human fetal HNPCs BrdU, Ki-67 MAP-2, DCX " # [38]
Rat fetal HNPCs Measurement of
neurosphere
diameter and
volume
GFAP b-III-tubulin CASP-3 # " # = [39]
IL-1a Rat fetal
mesencephalic
NPCs
TH "*
[37]IL-1b TH "*
IL-1b Rat fetal HNPCs [3H] thymidine FITC-labeled
annexin V
# #
[50]
IL-1bra [3H] thymidine FITC-labeled
annexin V
" "
IL-1b Rat fetal HNPCs BrdU # [49]
IL-1b Rat neonatal
DG NPCs
BrdU MAP-2, 5-HT # #**
[41]
IL-1ra MAP-2, 5-HT "**
IL-1b Rat adult DG NPCs BrdU TUNEL # = [40]
IL-1ra Rat adult DG NPCs BrdU DCX # #
[42]Co-treatment
with IL-1ra
BrdU "
LPS-MDM-
derived IL-1b***
Human fetal
cortical
NPCs
[3H] thymidine GFAP b-III-tubulin " " #
[51]
Pretreatment
with IL-1ra***
[3H] thymidine =
B. IL-6
Human-IL-6 Human fetal
STR NPCs,
human fetal HNPCs
GFAP, GalC b-III-tubulin = "
[59]Rat IL-6 GFAP, GalC b-III-tubulin = =
Neutralisation
of IL-6
Human fetal
cortical NPCs
GFAP "
[60]
Neutralisation
of LIF
GFAP #
LIF Rat fetal
mesencephalic
NPCs
TH "* [37]
IL-6 Rat adult DG NPCs BrdU GFAP, NG-2 b-III-tubulin,
DCX
TUNEL = = # "
[56]
Neutralisation
of IL-6
b-III-tubulin "
IL-6 Rat adult DG NPCs GFAP b-III-tubulin = " [55]
H-IL-6 Mouse fetal
SVZ NPCs
BrdU GFAP, MBP b-III-tubulin # " " [53]
IL-6 Mouse adult
DG NPCs
GFAP b-III-tubulin " # [54]
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Microglial-derived
IL-6 and LIF***
Rat fetal SVZ NPCs GFAP "
[61]
Microglial-derived
CNTF***
GFAP =
C. IL-4, IL-10, and IL-11
IL-11 Rat fetal
mesencephalic NPCs
TH "* [37]
IL-10 Mice adult SVZ NPCs Ki-67 NG-2 b-III-tubulin = = # [65]
IL-4-TM**** Mouse fetal
cortical NPCs
BrdU GFAP MAP-2 # " " #
[63]
IL-10-TM**** BrdU GFAP MAP-2 " = = #
IL-4-TM**** Mouse adult
SVZ NPCs
NG-2 DCX " " [67]
D. IFN-a and IFN-g
Human-IFN-g,
rats-IFN-g
Human fetal
STR NPCs
GFAP, GalC b-III-tubulin = "
[59]
Human-IFN g,
rats-IFN-g
Human fetal HNPCs GFAP, GalC b-III-tubulin " =
IFN-g Rat fetal HYNPCs GFAP b-III-tubulin " " [77]
IFN-g Rat fetal STR NPCs BrdU TUNEL # " [75]
IFN-a Mouse adult
DG NPCs
Total number of
neurospheres
#
[71]
IFN-a Cr2–/– mice DG NPCs Total number of
neurospheres
=
IFN-g Mouse fetal HYNPCs BrdU GFAP b-III-tubulin # " " [76]
IFN-g+TNF-a Mouse neonatal
SVZ NPCs
GFAP NeuN EGFP
expressed
under XYZ
protein
TUNEL " = " " [72]
IFN-g –TM**** Mouse adult
SVZ NPCs
NG-2 DCX " " [67]
E. TNF-a
TNF-a Human fetal HNPCs GFAP b-III-tubulin " # [38]
Human-TNF-a,
rats-TNF-a
Human fetal STR
NPCs, fetal HNPCs
GFAP, GalC b-III-tubulin CASP-3 " # " [59]
TNF-a Human fetal
cortical NPCs
GFAP b-III-tubulin " # [51]
Rat adult SVZ NPCs BrdU GFAP b-III-tubulin TUNEL " = = " [80]
GFAP b-III-tubulin " # [60]
Rat adult DG NPCs b-III-tubulin,
DCX
# [56]
Mouse neonatal
SVZ NPCs
b-III-tubulin " [79]
TNF-a + INF-U Mouse neonatal
SVZ NPCs
GFAP NeuN EGFP TUNEL " = " " [72]
TNF-a (1 ng/ml
mouse or human
recombinant)
Mouse neonatal
SVZ NPCs
BrdU NeuN " "
[81]TNF-a (10 and
100 ng/ml mouse
or human
recombinant)
TUNEL "
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differentiation [41]. IL-1b reduced proliferation as well as cell
apoptosis also in rat adult DG NPCs [42]. Interestingly, co-
incubation with an inhibitor of nuclear factor (NF)-kB blocked
the antiproliferative effect of IL-1b [42].
Recombinant IL-1b decreased neurogenesis, but en-
hanced astrogliogenesis in human fetal hippocampal (H)
NPCs [38,43] and in rat fetal HNPCs, without affecting cell
apoptosis [39]. Conversely, IL-1a and IL-1b enhanced
differentiation of rat fetal mesencephalic NPCs into dopa-
minergic (DA) neurons [37]. These apparent contrasting
findings are partially supported by results in
vivo. Evidence shows that IL-1 (a + b) promotes re-inner-
vation and differentiation of DA neurons in the STR and
mesencephalon [44,45], whereas both IL-1a and IL-1b
inhibit neurogenesis in the hippocampus [36].
Finally, despite decreasing neuronal differentiation, IL-
1b promoted cell proliferation in human fetal HNPCs
[43]. Previous findings have reported different effects on
proliferation upon IL-1b treatment. For example, repeated
but not single intrahippocampal injection with IL-1b en-
hanced proliferation, whereas there were no changes if
systemically administered [46]. Another study showed an
increase in proliferation in young but not older mice upon
IL-1a treatment, which acts through the same IL-1r as IL-
1b [47]. However, other pharmacological compounds have
also been shown to have differential effects on proliferation
versus differentiation, for example when cells are treated
with antidepressants [48].
The inhibitory effects of IL-1b on neurogenesis in human
fetal HNPCs are mediated, at least in part, by activation ofT
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Box 1. Molecular markers for cell proliferation and
differentiation
Distinct molecular markers have been used in vitro to detect NPCs
during the phase of proliferation or differentiation into neurons,
oligodendrocytes, and astrocytes [106]. Most of the current markers
used for in vitro NSCs and/or NPCs and derived differentiated cells
have been drawn from in vivo data. Namely, during development
progenitors have been labelled with SRY-related HMG box-2
transcription factor (SOX-2) and nestin [107,108]. In particular,
SOX-2 is a member of the SOX family of transcription factors
[108], whereas nestin is a type VI intermediate filament protein
[107]. Both markers detect Type 1 (quiescent radial NSCs, GFAP+
SOX-2+) hippocampal cells [3]. As the CNS develops, these markers
become increasingly restricted until adulthood, where they are only
expressed in adult NSCs [109]. In the DG, certain subtypes of adult
NPC also express the GFAP, specifically Type 1 (quiescent radial
NSCs, GFAP+ SOX-2+) hippocampal cells and Type B (quiescent
radial adult NSCs, GFAP+) SVZ cells [3]. However, such markers
cannot be used solely because SOX-2 can label both subtypes of
stem cell and glial cell (astrocytes) [110], suggesting the need to use
a combination of positive markers. Given that NPCs can self-renew,
another useful marker is the synthetic nucleoside BrdU, because it
indicates cell proliferation. Specifically, BrdU is a synthetic nucleo-
side that can be easily incorporated into the newly synthesized DNA
of replicating cells [111]. Furthermore, because BrdU labelling is an
indication that a cell has recently been dividing, when colabelled
with a mature marker of a specific CNS cell type, it will reveal the
fate of the newborn cells (namely neurogenesis when double
labelled with a neuronal marker) [100]. Finally, upon differentiation,
specific markers for neurogenesis and gliogenesis are expressed. In
particular, the neuronal migration protein DCX is detected in
immature neurons, and is a marker for the early stages of
neurogenesis [98]. Contrarily, GFAP is expressed in mature astro-
cytes and has become a prototypical marker for astrogliogenesis
[112].
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the kynurenine pathways and the production of neurotoxic
tryptophan metabolites [43]. In rat fetal mesencephalic
NPCs, activation of phospho-p38 mitogen-activated protein
kinases (MAPK) reversed the negative effect of IL-1b on cell
proliferation [39]. In rat fetal HNPCs, IL-1b reduced prolif-
eration and apoptosis via phosphorylation of the stress-
activated protein kinase (SAPK)/c-Jun N-terminal kinase
(JNK). Indeed, SAPK/JNK inhibitor or IL-1ra reversed the
inhibition of cell proliferation and apoptosis [49]. IL-1b-
induced impaired proliferation in rat fetal HNPCs was
partly mediated by activation of the enzyme glycogen
synthase kinase-3b (GSK-3b) and subsequent reduction of
the protein orphan nuclear receptor tailless homolog (TLX)
expression [50]. In fact, GSK-3b inhibition ameliorated the
effects of IL-1b on TLX expression in both proliferating and
differentiating cells [50]. In human fetal HNPCs, the inhibi-
tory effects of IL-1b on neurogenesis were mediated, at least
in part, by activation of signal transducer and activator of
transcription 3 (STAT3) pathway [38].
IL-1b induced by lipopolysaccharide-activated human
monocyte-derived macrophages. To our knowledge,
one study examined the role of IL-1b induced by lipopoly-
saccharide (LPS)-activated human monocyte-derived
macrophages (MDM) using conditioned media (CM) experi-
ments. IL-1b from LPS-MCM stimulated human fetal
cortical NPCs proliferation, although pretreatment withT
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Box 2. The relevance of inflammation for neurogenesis: the
translational link between in vitro and in vivo data
The inflammatory process in the neurogenic regions of the brain
significantly alters the microenvironment of the NPCs and conse-
quently influences the fate of these cells [9]. In vitro evidence
suggests that hyperactivation of the immune response impairs
progenitor survival and differentiation. However, some of the
inflammatory products, including cytokines, are proneurogenic
and, therefore, promote recovery [10]. Due to the complex mechan-
isms by which the immune system differently determines the final
developmental fate of the NPCs, further in vivo evidence is needed
to better clarify in vitro data. Particular attention should be given to
the dialogue between innate immunity (i.e., natural killer cells and
macrophages) and adaptive immunity (i.e., cytokines and lympho-
cytes), and the way they differently interact and/or stimulate one
another in the context of acute or chronic neurodegeneration
[113]. This might provide further insight into how the two types of
immunity contribute to the severity of these conditions. Moreover,
different brain insults, including stressors, diversely activate the
immune system, leading to either a potentiation or a reduction in
neurogenesis [58]. Therefore, understanding the inflammatory
pathways by which different challenges modulate neurogenesis
will contribute to the development of novel therapeutic targets
specific for the type of insult [10]. While in vitro findings help to
identify the molecular and cellular mechanisms underlying the
effects of inflammation on neurogenesis, clinical studies provide
further insight into the role of inflammation in the behavioural and
cognitive impairments seen in patients with depression and/or
neurodegenerative conditions. Therefore, future research should
focus on immune products, such as cytokines, especially on those
for which sufficient evidence has been accumulated on their
molecular and cellular effects on mood and cognitive functions,
ultimately allowing the possible translational link between in vitro
data and clinical applications to be determined [18]. Understanding
the mechanisms underlying the association between inflammation
and neurogenesis will have profound implications for the pathogen-
esis and treatment of neurodegenerative and neuropsychiatric
disorders.
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IL-1ra did not block this effect. The culture also decreased
neurogenesis but enhanced astrogliogenesis [51]. Results
suggest a direct involvement of MCM, but not of IL-1b, in
cell proliferation. In fact, it is possible that MCM alone
induced the production of other factors, such as cyclin-
dependent kinases (CDKs) [51], which are well known to
regulate the NPC cycle and positively influence cell prolif-
eration [52].
IL-6
In most studies, IL-6 reduces (or does not affect) prolifera-
tion and gliogenesis, while increases neuronal differentia-
tion (Table 1B), although some of the molecular
mechanisms activated by IL-6 in the brain depend on
the type of brain cells and on cell age [53,54].
IL-6 promoted neurogenesis in rat adult DG NPCs but
did not cause any considerable modifications in astroglio-
genesis [55]. By contrast, IL-6 decreased neurogenesis and
increased apoptosis in rat adult DG NPCs, without affect-
ing proliferation and gliogenesis, and a blocking antibody
to IL-6 restored neurogenesis [56]. Indeed, IL-6 may inhib-
it neurogenesis by reducing soluble factors, such as the
protein sonic hedgehog (SHH), which is known to promote
neuronal differentiation [57,58]. Finally, IL-6 inhibited
neurogenesis also in mice adult DG NPCs; however, it
enhanced astrogliogenesis in this experimental setting
[54]; the different types of cell culture, particularly if from
rat or mouse, could account for these discrepant results on
astrogliogenesis [59].
In contrast to rat-IL-6, human-IL-6 increased neurogen-
esis but not gliogenesis in either human fetal STR NPCs or
in human fetal HNPCs [59]. Similarly, hyper-IL-6 (H-IL-6;
a fusion of IL-6 and the soluble IL-6-receptor, sIL-6R)
decreased cell proliferation and increased neurogenesis,
but did not have any effect on gliogenesis in mouse fetal
SVZ NSCs [53]. In addition, neutralising antibody for the
leukaemia inhibitory factor (LIF), one of the IL-6 family
cytokines, but not for IL-6, reduced astrogliogenesis in
human fetal cortical NPCs [60]. LIF also induced differen-
tiation of rat fetal mesencephalic NPCs into DA neurons
[37].
In terms of mechanisms, in mouse adult DG NPCs, IL-6
decreased neurogenesis via activation of cyclin-dependent
kinase inhibitor 1A (p21) [54], whereas H-IL-6 increased
neurogenesis in mouse fetal SVZ NSCs via activation of the
MAPK/cAMP response element-binding protein (CREB)
cascade [53].
Microglial-derived IL-6-family cytokines. To our knowl-
edge, one study examined the role of microglial-derived IL-
6, LIF, and the ciliary neurotrophic factor (CNTF) on cell
proliferation and differentiation, using CM experiments.
Microglial-derived IL-6 CM and LIF CM, but not CNTF
CM, promoted astrogliogenesis in rat fetal SVZ NPCs
[61]. Previous in vivo evidence suggests that both IL-6
and LIF induce gliogenesis via inhibition of neuronal
differentiation. Indeed, IL-6 and LIF receptor complex
are involved in the activation of the transcription factor
hairy-enhancer-of-split 1 (HES-1), which in turns negative-
ly regulates neurogenesis and induces gliogenesis
[62]. However, this hypothesis cannot be confirmed here
because the authors did not investigate the neuronal fate of
the NPCs.
IL-4, IL-10, and IL-11
There are fewer studies on IL-4, IL-10, and IL-11, and not
all aspects of the neurogenic process have been examined
with all of them. However, some main findings have been
replicated in most studies: IL-4 reduces proliferation and
increases both neuronal and glial differentiation; IL-10 has
opposite effects, that is, increases (or does not affect)
proliferation and reduces (or does not affect) both neuronal
and glial differentiation; and IL-11 increases neuronal
differentiation (Table 1C). The different results reported
for IL-4 and IL-10 might depend on the different modalities
of cell treatment: cytokine-treated NPCs (with IL-10) or
cytokine-treated microglia (TM) (with IL-4 and Il-10), co-
incubated with NPCs [63]. However, in one study, IL-4-and
IL-10-TM had different effects on both proliferation and
differentiation [63], suggesting that not only the presence
of microglia per se, but also the type of microglia activator
(IL-4 or IL-10) influence cell fate in different ways [64].
IL-10 had no effect on both proliferation and oligoden-
drogenesis [65]. However, treatment with IL-10 in mouse
adult SVZ NPCs impaired neurogenesis [65]. In fact, ab-
sence of IL-10 in vivo induced neuronal differentiation of
SVZ NPCs and increased incorporation of new neurons in
the adult OB [65].
IL-11 promoted differentiation of rat fetal mesencephalic
NPCs into DA neurons [37]; however, there are no studies
using animal models, which prevents the complete under-
standing of the role of this cytokine for neurogenesis [66].
IL-4-and IL-10-TM. To our knowledge, two studies exam-
ined the role of IL-4-and IL-10-TM on cell generation.
Indeed, co-culture of mice adult SVZ NPCs with IL-4-
TM, but not with LPS-TM, induced neurogenesis and
oligodendrogenesis [67]. These results suggest that specific
stimuli (IL-4 or LPS) produce different types of activated
microglia, ultimately determining different cell fates. In
fact, here it is possible that quiescent microglia, residing in
the vicinity of the proliferating NPCs, become activated by
IL-4, but not by LPS to support neurogenesis, via putative
production of neurotrophic factors [68,69].
Co-culture of mouse fetal cortical NPCs with IL-4-or IL-
10-TM reduced or enhanced proliferation, respectively.
Furthermore, in contrast to IL-10-, IL-4-TM increased
neurogenesis and astrogliogenesis [63]. This again stresses
the importance of the type of inflammatory challenge (IL-4
or IL-10) in influencing microglia activation [64]. Most
importantly, co-culture with microglia only showed an
antiapoptotic effect, which was strengthened mainly by
IL-4-TM [63]. Therefore, it is possible that (IL-4-treated)
microglia were either antiapoptotic or prophagocytic,
which might in part explain the proneurogenic output [70].
IFN-a and IFN-g
In most studies, both IFN-a and IFN-g reduce prolifera-
tion, and IFN-g increases both neuronal and glial differ-
entiation (Table 1D). These results are relatively
consistent among the studies reviewed; however, in one
case, contradictory findings might be due to the use of cell
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cultures from specific brain regions, with distinct prolifer-
ating and differentiating properties [59].
IFN-a, a ligand of the complement receptor 2 (CR2),
impaired proliferation in mice adult DG NPCs. According-
ly, IFN-a treatment on mice lacking Cr2 (Cr2/) did not
affect proliferation [71]. In addition, combination treat-
ment with IFN-g +TNF-a caused no changes in neurogen-
esis in mice neonatal SVZ NPCs [72], suggesting that,
although IFN-g primarily shows proneurogenic properties,
TNF-a counterbalanced the effects of IFN-g by inhibiting
neurogenesis [73]. However, IFN-g+TNF-a enhanced
astrogliogenesis, cell migration, and apoptosis [72].
Human IFN-g or rat IFN-g enhanced neurogenesis, but
not gliogenesis in human fetal STR NPCs. By contrast,
when conducting the same experiment in human fetal
HNPCs, both treatments increased gliogenesis, but did
not alter neurogenesis [59]. These differences can partially
be explained by region-specific characteristics. In fact, the
hippocampus expresses higher levels of cytokines recep-
tors compared with the STR [74]. Here, human HNPCs had
a threefold higher level of IFN-g-r compared with human
STR NPCs [59], suggesting that the diverse receptor levels
affected the results. IFN-g also reduced proliferation and
enhanced apoptosis in rat fetal STR NPCs [75]. Likewise,
IFN-g impaired mouse fetal hypothalamic (HY) NPCs
proliferation, while it increased neurogenesis and astro-
gliogenesis. Of note, in one study, numerous cells co-
expressed beta-III tubulin (b-III-tubulin) and the glial
fibrillary acid protein (GFAP), but electrophysiological
results showed that cells were functionally distinct from
mature neurons as well as astrocytes, suggesting IFN-g as
a promoter of the dysregulated NPC-derived cellular phe-
notype [76]. Results were replicated, confirming a pheno-
typic dysregulation (b-III-tubulin-GFAP co-expression)
induced by IFN-g in rat fetal HYNPCs [77].
In the aforementioned studies examining phenotypic
dysregulation, genes, such as STAT1 and proteins, includ-
ing SHH, were upregulated by IFN-g [76,77]. Likewise,
previous experiments revealed that STAT1 and STAT2
signals are the major pathways for IFN-g-mediated func-
tions in vivo [78].
IFN-g-TM. To our knowledge, one study examined the
effect of IFN-g-TM on cell differentiation. Co-culture of
20 ng/ml IFN-g-TM with mouse adult SVZ NPCs induced
both neuronal and glia differentiation [67]. Indeed, previ-
ous data demonstrated that the effect of IFN-g in confer-
ring a neuroprotective phenotype on microglia is mainly
restricted to a low range of concentrations (1–50 ng/ml)
[68], which in part explains the positive results found here
upon IFN-g treatment [67].
TNF-a
In most studies, TNF-a increases proliferation and glio-
genesis, but reduces neurogenesis (Table 1E). Few studies
reported contradictory results, which might be due to the
use of diverse types of cell culture, particularly mouse [79]
or rat samples [80].
Treatment with TNF-a+INF-g had no effect on neuro-
genesis; however, it increased astrogliogenesis, cell migra-
tion, and apoptosis in mouse neonatal SVZ NPCs (see IFN-g
subsection) [72]. Conversely, TNF-a reduced neurogenesis
in rat adult DG NPCs [56] and promoted apoptosis in rat
adult SVZ NPCs [80]. TNF-a increased also proliferation,
but it did not affect neurogenesis and astrogliogenesis
[80]. By contrast, TNF-a increased neuronal differentiation
in mouse neonatal SVZ NPCs [79]. Likewise, a low dosage of
TNF-a (1 ng/ml mouse or human recombinant) increased
proliferation and neurogenesis in mouse neonatal SVZ
NPCs, whereas a higher dosage (10 and 100 ng/ml mouse
or human recombinant) induced apoptosis [81]. In addition
to dosage-related difference, the effects of TNF-a on neuro-
genesis also have species differences. Indeed, although
TNF-a exerts neuroprotective properties in rat hippocampal
neurons [82], it is toxic to mouse-derived neurospheres,
because it interferes with their formation [83].
Human TNF-a or rat TNF-a impaired neurogenesis in
both human fetal STR NPCs and HNPCs, whereas they
promoted gliogenesis and apoptosis [59]. Likewise, TNF-a
decreased neurogenesis but enhanced astrogliogenesis in
human fetal HNPCs [38] and in rat adult SVZ NPCs
[60]. TNF-a increased astrogliogenesis, but inhibited neu-
rogenesis also in human fetal cortical NPCs [51].
In mouse neonatal SVZ NPCs, activation of NF-kB
signalling increased TNF-a-induced neuronal differentia-
tion; in fact, treatment with an NF-kB-specific inhibitor
IkB kinase (IKKb)-V prevented this effect [79]. Conversely,
TNF-a reduced neurogenesis in human fetal HNPCs via
activation of STAT-3 pathway [38].
TNF-a induced by LPS-MDM. To our knowledge, one study
has examined the role of TNF-a induced by LPS-MDM on
cell generation, using CM experiments. The culture en-
hanced cell proliferation and astrogliogenesis, but de-
creased neurogenesis in human fetal cortical NPCs
[51]. Accordingly, pretreatment with TNF-a receptors R1
and R2 (TNF-R1R2) reduced the effect of TNF-a on prolif-
eration [51]. Although TNF-a involvement in modulating
cell proliferation was further confirmed by a dose-depen-
dent increase in S-phase (via Cyclin D1 detection) [51],
MCM may have also had a role in determining cell fate. In
fact, here TNF-a in MCM upregulated the transcription
factor HES-1, previously known for its antineurogenic
properties [62], suggesting that TNF-a in MCM directly
contributed to the impaired neuronal differentiation.
Factors regulating the effects of cytokines on
neurogenesis
This review highlights the important role of cytokines as
major regulators of cell proliferation and differentiation. In
summary: IL-1a promotes neurogenesis, whereas IL-1b
decreases proliferation and neurogenesis, and increases
gliogenesis; IL-4 decreases cell proliferation, while IL-10
has stimulating or no effects; IL-4 and IL-11 enhance
neurogenesis and/or gliogenesis, whereas IL-10 decreases
(or has no effect) on cell differentiation; IL-6, IFN-a, and
IFN-g all reduce (or have no effect) on proliferation, where-
as only IL-6 and IFN-g increase (or have no effect) on both
neuronal differentiation and gliogenesis; and, finally, TNF-
a increases proliferation and gliogenesis, but inhibits neu-
rogenesis. Overall, the evidence indicates that inflamma-
tory cytokines have both positive and negative regulatory
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roles in all processes integral to neurogenesis, including
NSC proliferation, fate specification, young neuron migra-
tion, and neuronal maturation. However, although we
have attempted to draw common conclusions from the
different studies, there are inevitably several methodolog-
ical issues that might have contributed to the many con-
trasting results.
First and foremost, the use of different types of cell
culture, particularly human or animal cells, is an important
aspect to be taken into consideration. Studies reviewed here
provided evidence for divergent responses between human
and animal cells after exposure to specific cytokines, includ-
ing IL-1b [37,39–42,49,50], IFN-g [67,76,77], and TNF-a
[72,79–81]. In fact, while these modulators induce a striking
dysregulation in neuronal formation in animals, they have
diverse effects in human NSCs [78,84]. One possible expla-
nation might be due to a qualitatively different activation of
molecular downstream signals in rat versus human cells
[85–87]. For example, IL-1b has an important role in acti-
vating TGF b, which has been considered one of the main
mediators of NPC proliferation [88]. In human cells, IL-1b
stimulates the production of TGF-b mainly in astrocytes
[89], whereas in rats, IL-1b enhances TGF-b formation
mainly in oligodendrocytes [89], suggesting specific molecu-
lar effects of IL-1b on different cell types [90]. Likewise,
treatment with IFN-g of murine NSCs, but not of human
NSCs, significantly upregulates SHH, which in turn has an
important role in influencing the pattern of the CNS during
embryonic growth, via expression of a unique combination of
transcription factors that leads to neuronal cell fate differ-
entiation [91]. TNF-a also has species-dependent effects.
Using a rat stroke model with TNF-a antibody, one study
reported a decrease in striatal and hippocampal neurons via
TNF-R1, proposing TNF-a as a promoter for survival of
newly generated neurons [92]; however, other evidence
demonstrates the involvement of TNF-a in the activation
of inflammatory mediators in human NPCs that are known
to contribute to the development of neurodegenerative dis-
orders, including chemokine C-X-C motif ligand 2 (CXCL2),
CXCL10, and CXCL12 [93,94]. Hence, cytokine-induced
specific signalling pathways, differently activated between
human and rodent models, may lead to qualitative differ-
ences in the development of cellular phenotypes [90]. Future
research is needed to clarify whether and how effects of
cytokines on neurogenesis are different in humans and
rodents, and whether this is due to the activation of diverse
molecular downstream signals. Indeed, new in vivo data,
comparing animal and human samples, will allow for a
better understanding and a more accurate interpretation
of the in vitro findings (Box 2).
Contradictory results might also be due to the use of cell
cultures derived from diverse brain regions, with specific
proliferating and differentiating properties [95]. Studies
reviewed here showed divergent reactions in distinct brain
cells after exposure to the same cytokines, regardless of
whether they assessed adult or fetal developmental neu-
rogenesis. For example, there is evidence that IL-1b
induces a reduction in cell proliferation and neurogenesis
in the SGZ [87], causing a shift in cell lineage from neuro-
nal to astroglial [96]; and that it has the same effect on
proliferating cells in the SVZ, but in this case it prevents
lineage progression, leaving NSCs undifferentiated
[96]. Treatment of cultured astrocytes with H-IL-6 induces
region-specific morphological changes of astrocytes from
typical stellate-to fibrous-like cells only in cortex-and hip-
pocampus-derived astroglia, while astrocytes derived from
other brain regions, such as STR or cerebellum, fail to
respond to H-IL-6 [97]. TNF-a has pro- and antiprolifera-
tive and neurogenic properties in SVZ cells and meningeal
cells, respectively [73]. Again, future studies should clarify
the influence of distinct cytokines on specific cell types,
derived from diverse brain regions, and the molecular
mechanisms underlying these specific responses.
Finally, contrasting findings might also be attributed to
the variability in the expression of distinct molecular
markers in different experimental settings. While most
studies labelled proliferating cells using bromodeoxyuri-
dine (BrdU) [98], this simple procedure has several dis-
advantages. For example, high or nonsaturating doses of
BrdU might be toxic, and can cause inconsistent or partial
labelling of proliferating cells [99]. Furthermore, specific
treatments, for example with glucocorticoids, might also
influence the bioavailability of BrdU [100]. Doublecortin
(DCX) is a reliable marker to identify neuronal differenti-
ation [98], because it does not require in vivo labelling of
proliferating cells [100]. DCX is widely expressed in brain
cells, including in morphologically differentiated neurons,
such as the neurons in the cortex, STR, and corpus callo-
sum [101]. However, DCX also has disadvantages because
it cannot provide accurate information about long-term
survival of newly generated neurons (i.e., beyond 30 days)
[102]. DCX is highly expressed during the initial phase of
cell differentiation (when neuroblasts are formed), reaches
its peak during the second week, and starts to downregu-
late before neuronal maturation [98]. In fact, there is
evidence that cells in adult neurogenic regions lose their
ability to express DCX, and instead markers for mature
glia (GFAP) and neurons (b-III-tubulin) are detected
[100]. Indeed, GFAP is used for labelling mature astrocytes
[100], and is expressed in distinct subpopulation of cells
that have similar multipotent properties as those found in
NSCs [103]. However, GFAP is sometimes associated with
unusual b-III-tubulin co-expression, even if cells are func-
tionally different from astrocytes as well as neurons, rais-
ing concerns about its validity and reliability as the main
marker of gliogenesis [104]. There are also still many
uncertainties on the role of b-III-tubulin as an effective
marker for neurogenesis [104]: although detection of b-III-
tubulin in differentiated NSCs is usually interpreted as
enhanced neurogenesis [105], sometimes neurons expres-
sing this marker appear to be dysregulated in terms of
functional and molecular properties [104]. Hence, the de-
bate on the validity and the efficacy of such molecular
markers is still open. Future studies should identify new
cell markers that could track accurately the different
stages of neurogenesis, starting from the early stage of
neuronal determination, and ending as differentiating
neurons reach maturation [100].
Concluding remarks
Despite the limitations of the available literature, to our
knowledge this is the first review summarising the role of
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inflammatory cytokines on cell proliferation and differen-
tiation, discussing in vitro human and animal studies.
Overall, our findings confirm and extend evidence for
inflammatory cytokines to have both positive and negative
regulatory roles in all processes integral to neurogenesis,
including NSC proliferation, fate specification, young neu-
ron migration, and neuronal maturation, and thus in
monitoring the normal functioning of the brain. Hence,
this strengthens the notion that inflammation, particular-
ly neuroinflammation, is relevant for the pathogenesis of
neuropsychiatric and behavioural disorders, including
neurodegenerative diseases and depression. We would
further argue that the molecular mechanisms by which
cytokines affect neurogenesis should be considered as
therapeutic targets for these disorders. However, these
molecular mechanisms are likely to be species specific
and even brain area specific and, therefore, dissecting such
mechanisms remains an important and clinically signifi-
cant challenge.
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